Sodium-dependent Glucose Cotransporter (SGLT)



7 Item(s)

per page

Set Descending Direction
Catalog No. Product Name Application Product Information
A11100

Canagliflozin

SGLT2 Inhibitor
Canagliflozin is an inhibitor of subtype 2 sodium-glucose transport protein (SGLT2).
A10285

Dapagliflozin (BMS512148)

SGLT2 inhibitor
Dapagliflozin inhibits subtype 2 of the sodium-glucose transport proteins (SGLT2), which is responsible for at least 90% of the glucose reabsorption in the kidney.
A10155

EGT1442

SGLT2 inhibitor
EGT1442 is a potent and selective SGLT2 inhibitor.
A12440

Empagliflozin

-
Empagliflozin is a potent, selective sodium glucose co-transporter-2 inhibitor that is in development for the treatment of type 2 diabetes.
A13556

Ipragliflozin

-
Ipragliflozin is a highly potent and selective SGLT2 inhibitor with IC50 of 2.8 nM; little and NO potency for SGLT1/3/4/5/6.
A12680

LX-4211

SGLT Inhibitor‎
LX4211 is a Dual SGLT1/SGLT2 Inhibitor
A12690

Tofogliflozin

SGLT2 inhibitor
Tofogliflozin is an inhibitor of subtype 2 sodium-glucose transport protein (SGLT2), which is responsible for at least 90% of the glucose reabsorption in the kidney.

7 Item(s)

per page

Set Descending Direction